Response to Stavropoulos.
University of Pennsylvania, Philadelphia, PA, USA.
Raymond R
RR
Townsend
Canvas Clinical Research, Lake Worth, FL, USA.
Israel
I
Machin
Janssen Pharmaceuticals Inc, Raritan, NJ, USA.
Jimmy
J
Ren
La Pine, OR, USA.
Angelina
A
Trujillo
JCHO Yufuin Hospital, Oita, Japan.
Masato
M
Kawaguchi
Janssen Research & Development, LLC, Raritan, NJ, USA.
Ujjwala
U
Vijapurkar
Janssen Research & Development, LLC, Raritan, NJ, USA.
C V
CV
Damaraju
Janssen Pharmaceuticals Inc, Raritan, NJ, USA.
Michael
M
Pfeifer
D000068896:Canagliflozin / Q000627:therapeutic use; D003924:Diabetes Mellitus, Type 2 / Q000150:complications*; D006801:Humans; D006973:Hypertension / Q000188:drug therapy*; D007004:Hypoglycemic Agents / Q000627:therapeutic use
D007004:Hypoglycemic Agents; D000068896:Canagliflozin